These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND MYOD1, ENSG00000129152, 4654, P15172, PUM, MYOD, MYF3 AND Prognosis
3 results:

  • 1. Automated Analysis of Lymphocytic Infiltration, Tumor Budding, and Their Spatial Relationship Improves Prognostic Accuracy in colorectal cancer.
    Nearchou IP; Lillard K; Gavriel CG; Ueno H; Harrison DJ; Caie PD
    Cancer Immunol Res; 2019 Apr; 7(4):609-620. PubMed ID: 30846441
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Methylation of the polycomb group target genes is a possible biomarker for favorable prognosis in colorectal cancer.
    Dallol A; Al-Maghrabi J; Buhmeida A; Gari MA; Chaudhary AG; Schulten HJ; Abuzenadah AM; Al-Ahwal MS; Sibiany A; Al-Qahtani MH
    Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):2069-75. PubMed ID: 23010642
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Hypermethylation of the myod1 gene is a novel prognostic factor in patients with colorectal cancer.
    Hiranuma C; Kawakami K; Oyama K; Ota N; Omura K; Watanabe G
    Int J Mol Med; 2004 Mar; 13(3):413-7. PubMed ID: 14767572
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.